Physician profile
Michael B Spackman
NPI 1386887032
$3,173.36
in general payments reported to CMS, 2019-2025
15 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $194 · 2021: $292 · 2022: $1,338 · 2023: $236 · 2024: $544 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,280.20 | 2022 | |
| Medtronic, INC. | $833.20 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbott Laboratories | $581.54 | 2019-2025 | Eterna, Proclaim, Penta |
| Spinefrontier, INC. | $87.21 | 2025 | Facetfuse, Nanofuse, Sijfuse |
| Biodelivery Sciences International, INC. | $68.25 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $66.04 | 2019-2021 | |
| Medtronic USA, INC. | $56.23 | 2019-2020 | |
| Dexcom, INC. | $38.09 | 2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.41 | 2020-2022 | |
| Lilly USA, LLC | $32.40 | 2021 | |
| Baxter Healthcare | $29.68 | 2025 | Perclot |
| Horizon Therapeutics Plc | $24.58 | 2019 | |
| Boston Scientific Corporation | $15.05 | 2023 | |
| Pfizer INC. | $14.09 | 2021 | |
| Stimwave Technologies Incorporated | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Spackman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.